Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
ESMO Open|February 17, 2026
Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancerY Katayama, A Fukuda, R Inoue, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progressionK Morimoto, T Yamada, N Furuya, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 3, 2019
Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodiesT Sakakida, T Ishikawa, Y Chihara, et al.
Pageof 2